# Core D: Digital Pathology and CyTOF

> **NIH NIH P01** · JOHNS HOPKINS UNIVERSITY · 2021 · $349,207

## Abstract

PROJECT SUMMARY
The Digital Pathology and Mass Cytometry Core (Core D) will provide state-of-the-art technologies to enable
high-parameter single-cell proteomic profiling for all the Research Projects in the proposed P01 Program Project
Grant. The core directors are experts in multicolor immune profiling (multispectral immunoflurescence staining)
and high-dimensional proteomic profiling (Cytometry by Time-of-Flight; CyTOF) technologies and will work with
project investigators to assay human and mouse tissues generated over the five years of the Program Project.
Dr. Anders (core co-director) is an Associate Professor of Pathology, is a practicing GI surgical pathologist who
co-directs the Tumor Microenvironment (TME) Laboratory in the Bloomberg Kimmel Institute for Cancer
Immunotherapy. The core houses approximately 6 million dollars of equipment aimed at multicolor tissue staining
and analysis. The major equipment includes 2 Leica Bond automated immunostainers, 6 Akoya automated high
capacity multichannel high-resolution scanning microscopes (Vectra and Polaris systems), and 8 data servers
linked by 10G and 40G internet connections to the rest of the campus. The TME laboratory is a central resource
for multispectral immunofluorescence staining and image analysis for the Johns Hopkins Oncology research
community. Dr. Ho (core co-director) is an Assistant Professor of Oncology and Scientific Director of the newly
established CyTOF core, housing the third-generation cytometer Helios™, in the Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins. Dr. Ho completed his postdoctoral research in the laboratory of Dr. Elizabeth
Jaffee with a special emphasis on developing mass cytometry pipelines to profile the immunologic responses.
Dr. Ho also co-led the development of analytical pipelines for CyTOF datasets with Dr. Elana Fertig
(Bioinformatics and leader for Core C). Both directors, Anders and Ho, have demonstrated a strong track record
of productivity utilizing these technologies. The lab spaces and offices dedicated to this Core are located in close
proximity within the Cancer Research Building Complex.
The goal of the Digital Pathology and Mass Cytometry Core (Core D) is to provide established and validated
assay platforms. The Core Directors have already set-up the assay systems and validated specific marker
panels. This provides quality assurance and control for assays performed within and across projects. Once
acquired, the data will be provided to Core C for analysis and integration, and to Core B for clinical
correlations.

## Key facts

- **NIH application ID:** 10170027
- **Project number:** 1P01CA247886-01A1
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** ROBERT A. ANDERS
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $349,207
- **Award type:** 1
- **Project period:** 2021-06-01 → 2026-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10170027

## Citation

> US National Institutes of Health, RePORTER application 10170027, Core D: Digital Pathology and CyTOF (1P01CA247886-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10170027. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*